Repurposing dye ligands as antivirals via a docking approach on viral membrane and globular proteins - SARS-CoV-2 and HPV-16
Description
A series of dye ligands are docked to three different proteins, E and 3a of severe acute respiratory syndrome corona virus type 2 (SARS-CoV-2) and E6 of human papilloma virus type 16 (HPV-16) using three different software. A four-level selection
